Phibro Animal Health Corporation
PAHC
$38.25
-$0.33-0.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 106.61% | 199.55% | 376.73% | 289.61% | 1,897.68% |
| Total Depreciation and Amortization | 13.14% | 20.02% | 31.40% | 37.66% | 27.18% |
| Total Amortization of Deferred Charges | 11.76% | 18.16% | 31.20% | 40.96% | 38.77% |
| Total Other Non-Cash Items | 80.95% | 902.32% | 1,189.60% | 608.40% | -60.92% |
| Change in Net Operating Assets | -341.04% | -832.97% | -1,161.29% | -278.40% | -165.11% |
| Cash from Operations | -13.94% | -24.23% | 67.61% | -8.59% | -8.53% |
| Capital Expenditure | -54.30% | -39.60% | -13.89% | 1.91% | 7.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 101.83% | 101.48% | -8,630.32% | -8,630.32% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -134.23% | -135.66% | -136.89% | 105.19% | 1,083.51% |
| Cash from Investing | 75.25% | 78.66% | 76.61% | -757.58% | -499.01% |
| Total Debt Issued | -74.33% | -77.58% | -76.64% | -11.50% | 317.98% |
| Total Debt Repaid | 69.35% | 72.78% | 67.41% | 46.11% | -250.31% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.07% | -0.07% | -0.08% | -0.06% | -0.04% |
| Other Financing Activities | 94.54% | 100.00% | 100.00% | 100.00% | -- |
| Cash from Financing | -103.17% | -105.87% | -116.80% | 778.10% | 3,160.49% |
| Foreign Exchange rate Adjustments | 313.37% | 203.84% | 138.02% | 23.22% | 65.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.19% | -153.56% | -133.98% | 141.04% | -108.78% |